HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignant histiocytosis: complete remission with combination chemotherapy.

Abstract
A case of a 16-year-old girl with malignant histiocytosis involving the lymph nodes, bone marrow, peripheral blood, liver, and spleen is described. This patient achieved a complete remission with cyclic quadruple chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, and prednisone (COPP). She is alive and free of disease more than 4 years after the completion of COPP and after having had maintenance treatment with a small dose of cyclophosphamide for 2 3/4 years. Such good results with the COPP regimen in malignant histiocytosis have not been reported previously, and it is suggested that this modality of treatment warrants further trial.
AuthorsR S Stein, E M Moran, G E Byrne Jr
JournalCancer (Cancer) Vol. 38 Issue 3 Pg. 1083-6 (Sep 1976) ISSN: 0008-543X [Print] United States
PMID953957 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Procarbazine
  • Vincristine
  • Cyclophosphamide
  • Prednisone
Topics
  • Adolescent
  • Cyclophosphamide (administration & dosage)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lymphatic Diseases (drug therapy, pathology)
  • Prednisone (administration & dosage)
  • Procarbazine (administration & dosage)
  • Remission, Spontaneous
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: